nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazamide—Digestion impaired—Melphalan—peripheral nervous system neoplasm	0.025	0.025	CcSEcCtD
Tolazamide—Heartburn—Topotecan—peripheral nervous system neoplasm	0.0248	0.0248	CcSEcCtD
Tolazamide—Eruption—Dactinomycin—peripheral nervous system neoplasm	0.0225	0.0225	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Vincristine—peripheral nervous system neoplasm	0.0212	0.0213	CcSEcCtD
Tolazamide—Inappropriate antidiuretic hormone secretion—Cisplatin—peripheral nervous system neoplasm	0.0188	0.0188	CcSEcCtD
Tolazamide—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.0134	0.0134	CcSEcCtD
Tolazamide—Aplastic anaemia—Dactinomycin—peripheral nervous system neoplasm	0.013	0.013	CcSEcCtD
Tolazamide—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.0122	0.0122	CcSEcCtD
Tolazamide—Abdominal distension—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Tolazamide—Abdominal distension—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Tolazamide—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.0102	0.0102	CcSEcCtD
Tolazamide—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.00994	0.00995	CcSEcCtD
Tolazamide—Photosensitivity reaction—Tretinoin—peripheral nervous system neoplasm	0.00968	0.00969	CcSEcCtD
Tolazamide—Photosensitivity reaction—Isotretinoin—peripheral nervous system neoplasm	0.00968	0.00969	CcSEcCtD
Tolazamide—Eruption—Epirubicin—peripheral nervous system neoplasm	0.00911	0.00913	CcSEcCtD
Tolazamide—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.009	0.00901	CcSEcCtD
Tolazamide—Agranulocytosis—Tretinoin—peripheral nervous system neoplasm	0.00883	0.00884	CcSEcCtD
Tolazamide—Agranulocytosis—Isotretinoin—peripheral nervous system neoplasm	0.00883	0.00884	CcSEcCtD
Tolazamide—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.00878	0.00879	CcSEcCtD
Tolazamide—Eruption—Doxorubicin—peripheral nervous system neoplasm	0.00843	0.00844	CcSEcCtD
Tolazamide—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00823	0.00824	CcSEcCtD
Tolazamide—Abdominal distension—Alitretinoin—peripheral nervous system neoplasm	0.00809	0.0081	CcSEcCtD
Tolazamide—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00796	0.00797	CcSEcCtD
Tolazamide—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00739	0.0074	CcSEcCtD
Tolazamide—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00739	0.0074	CcSEcCtD
Tolazamide—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.00736	0.00737	CcSEcCtD
Tolazamide—Photosensitivity reaction—Alitretinoin—peripheral nervous system neoplasm	0.00734	0.00735	CcSEcCtD
Tolazamide—Agranulocytosis—Dactinomycin—peripheral nervous system neoplasm	0.00721	0.00722	CcSEcCtD
Tolazamide—Photosensitivity reaction—Vincristine—peripheral nervous system neoplasm	0.00707	0.00708	CcSEcCtD
Tolazamide—Ill-defined disorder—Topotecan—peripheral nervous system neoplasm	0.00691	0.00692	CcSEcCtD
Tolazamide—Ill-defined disorder—Isotretinoin—peripheral nervous system neoplasm	0.00686	0.00687	CcSEcCtD
Tolazamide—Ill-defined disorder—Tretinoin—peripheral nervous system neoplasm	0.00686	0.00687	CcSEcCtD
Tolazamide—Malaise—Topotecan—peripheral nervous system neoplasm	0.00672	0.00673	CcSEcCtD
Tolazamide—Agranulocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00669	0.0067	CcSEcCtD
Tolazamide—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00667	0.00668	CcSEcCtD
Tolazamide—Malaise—Isotretinoin—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Tolazamide—Malaise—Tretinoin—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Tolazamide—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00653	0.00654	CcSEcCtD
Tolazamide—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Tolazamide—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00638	0.00639	CcSEcCtD
Tolazamide—Discomfort—Topotecan—peripheral nervous system neoplasm	0.00627	0.00627	CcSEcCtD
Tolazamide—Discomfort—Tretinoin—peripheral nervous system neoplasm	0.00622	0.00622	CcSEcCtD
Tolazamide—Discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00622	0.00622	CcSEcCtD
Tolazamide—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00604	0.00605	CcSEcCtD
Tolazamide—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00596	0.00597	CcSEcCtD
Tolazamide—Thrombocytopenia—Topotecan—peripheral nervous system neoplasm	0.00595	0.00596	CcSEcCtD
Tolazamide—Thrombocytopenia—Isotretinoin—peripheral nervous system neoplasm	0.00591	0.00591	CcSEcCtD
Tolazamide—Thrombocytopenia—Tretinoin—peripheral nervous system neoplasm	0.00591	0.00591	CcSEcCtD
Tolazamide—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.0059	0.00591	CcSEcCtD
Tolazamide—Thrombocytopenia—Melphalan—peripheral nervous system neoplasm	0.00583	0.00584	CcSEcCtD
Tolazamide—Ill-defined disorder—Dactinomycin—peripheral nervous system neoplasm	0.00561	0.00561	CcSEcCtD
Tolazamide—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.0056	0.00561	CcSEcCtD
Tolazamide—Malaise—Dactinomycin—peripheral nervous system neoplasm	0.00545	0.00545	CcSEcCtD
Tolazamide—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00541	0.00541	CcSEcCtD
Tolazamide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00535	0.00536	CcSEcCtD
Tolazamide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00531	0.00532	CcSEcCtD
Tolazamide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00531	0.00532	CcSEcCtD
Tolazamide—Aplastic anaemia—Epirubicin—peripheral nervous system neoplasm	0.00526	0.00527	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00525	0.00526	CcSEcCtD
Tolazamide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00524	0.00525	CcSEcCtD
Tolazamide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00524	0.00525	CcSEcCtD
Tolazamide—Agranulocytosis—Etoposide—peripheral nervous system neoplasm	0.00522	0.00523	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00521	0.00521	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00521	0.00521	CcSEcCtD
Tolazamide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.0052	0.00521	CcSEcCtD
Tolazamide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.0052	0.00521	CcSEcCtD
Tolazamide—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00514	0.00515	CcSEcCtD
Tolazamide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00513	0.00514	CcSEcCtD
Tolazamide—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00508	0.00509	CcSEcCtD
Tolazamide—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00505	0.00506	CcSEcCtD
Tolazamide—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00501	0.00502	CcSEcCtD
Tolazamide—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00497	0.00498	CcSEcCtD
Tolazamide—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00497	0.00498	CcSEcCtD
Tolazamide—Aplastic anaemia—Doxorubicin—peripheral nervous system neoplasm	0.00487	0.00488	CcSEcCtD
Tolazamide—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00485	0.00485	CcSEcCtD
Tolazamide—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00483	0.00484	CcSEcCtD
Tolazamide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00483	0.00484	CcSEcCtD
Tolazamide—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00483	0.00483	CcSEcCtD
Tolazamide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00479	0.0048	CcSEcCtD
Tolazamide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00479	0.0048	CcSEcCtD
Tolazamide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00477	0.00478	CcSEcCtD
Tolazamide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00473	0.00474	CcSEcCtD
Tolazamide—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00471	0.00472	CcSEcCtD
Tolazamide—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00448	0.00448	CcSEcCtD
Tolazamide—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00443	0.00443	CcSEcCtD
Tolazamide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00436	0.00437	CcSEcCtD
Tolazamide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Tolazamide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00433	0.00433	CcSEcCtD
Tolazamide—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00431	0.00432	CcSEcCtD
Tolazamide—Malaise—Cisplatin—peripheral nervous system neoplasm	0.0043	0.00431	CcSEcCtD
Tolazamide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.0043	0.00431	CcSEcCtD
Tolazamide—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00427	0.00428	CcSEcCtD
Tolazamide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00427	0.00428	CcSEcCtD
Tolazamide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Tolazamide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00427	0.00427	CcSEcCtD
Tolazamide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00425	0.00426	CcSEcCtD
Tolazamide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00421	0.00422	CcSEcCtD
Tolazamide—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.00417	0.00418	CcSEcCtD
Tolazamide—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.00409	0.00409	CcSEcCtD
Tolazamide—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00406	0.00407	CcSEcCtD
Tolazamide—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00406	0.00406	CcSEcCtD
Tolazamide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00402	0.00403	CcSEcCtD
Tolazamide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00402	0.00403	CcSEcCtD
Tolazamide—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00401	0.00402	CcSEcCtD
Tolazamide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Tolazamide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00399	0.00399	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00395	0.00395	CcSEcCtD
Tolazamide—Malaise—Etoposide—peripheral nervous system neoplasm	0.00394	0.00395	CcSEcCtD
Tolazamide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00394	0.00395	CcSEcCtD
Tolazamide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00393	0.00393	CcSEcCtD
Tolazamide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00391	0.00392	CcSEcCtD
Tolazamide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Tolazamide—Rash—Topotecan—peripheral nervous system neoplasm	0.00383	0.00384	CcSEcCtD
Tolazamide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00381	0.00382	CcSEcCtD
Tolazamide—Headache—Topotecan—peripheral nervous system neoplasm	0.00381	0.00381	CcSEcCtD
Tolazamide—Rash—Tretinoin—peripheral nervous system neoplasm	0.0038	0.00381	CcSEcCtD
Tolazamide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0038	0.00381	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.0038	0.00381	CcSEcCtD
Tolazamide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0038	0.0038	CcSEcCtD
Tolazamide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00378	0.00379	CcSEcCtD
Tolazamide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00378	0.00378	CcSEcCtD
Tolazamide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00378	0.00378	CcSEcCtD
Tolazamide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Tolazamide—Rash—Melphalan—peripheral nervous system neoplasm	0.00375	0.00376	CcSEcCtD
Tolazamide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Tolazamide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00363	0.00364	CcSEcCtD
Tolazamide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00361	0.00362	CcSEcCtD
Tolazamide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00358	0.00359	CcSEcCtD
Tolazamide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00358	0.00359	CcSEcCtD
Tolazamide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00354	0.00355	CcSEcCtD
Tolazamide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Tolazamide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Tolazamide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00349	0.0035	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00336	0.00337	CcSEcCtD
Tolazamide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00334	0.00334	CcSEcCtD
Tolazamide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Tolazamide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Tolazamide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00323	0.00324	CcSEcCtD
Tolazamide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Tolazamide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00321	0.00321	CcSEcCtD
Tolazamide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Tolazamide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00311	0.00311	CcSEcCtD
Tolazamide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00309	0.00309	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Tolazamide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00308	0.00308	CcSEcCtD
Tolazamide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00302	0.00303	CcSEcCtD
Tolazamide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.00297	0.00297	CcSEcCtD
Tolazamide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00294	0.00294	CcSEcCtD
Tolazamide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Tolazamide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Tolazamide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00291	0.00292	CcSEcCtD
Tolazamide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00288	0.00289	CcSEcCtD
Tolazamide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00286	0.00287	CcSEcCtD
Tolazamide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00283	0.00284	CcSEcCtD
Tolazamide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00279	0.0028	CcSEcCtD
Tolazamide—Rash—Vincristine—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Tolazamide—Headache—Vincristine—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Tolazamide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00272	0.00272	CcSEcCtD
Tolazamide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Tolazamide—Nausea—Vincristine—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Tolazamide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Tolazamide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00252	0.00253	CcSEcCtD
Tolazamide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Tolazamide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00245	0.00245	CcSEcCtD
Tolazamide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00236	0.00236	CcSEcCtD
Tolazamide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00232	CcSEcCtD
Tolazamide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00227	0.00228	CcSEcCtD
Tolazamide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00227	0.00227	CcSEcCtD
Tolazamide—Rash—Etoposide—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Tolazamide—Headache—Etoposide—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Tolazamide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00221	0.00221	CcSEcCtD
Tolazamide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0022	0.0022	CcSEcCtD
Tolazamide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00219	0.0022	CcSEcCtD
Tolazamide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Tolazamide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.0021	0.00211	CcSEcCtD
Tolazamide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Tolazamide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00205	0.00205	CcSEcCtD
Tolazamide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00204	0.00204	CcSEcCtD
Tolazamide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Tolazamide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Tolazamide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Tolazamide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Tolazamide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00173	0.00173	CcSEcCtD
Tolazamide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00172	0.00173	CcSEcCtD
Tolazamide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00165	0.00165	CcSEcCtD
Tolazamide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Tolazamide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Tolazamide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.0016	0.0016	CcSEcCtD
Tolazamide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00159	0.00159	CcSEcCtD
Tolazamide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Tolazamide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00147	CcSEcCtD
Tolazamide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Tolazamide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00142	0.00142	CcSEcCtD
Tolazamide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Tolazamide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00132	CcSEcCtD
Tolazamide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00131	0.00131	CcSEcCtD
Tolazamide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Tolazamide—Headache—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Tolazamide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.00123	CcSEcCtD
Tolazamide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Tolazamide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Tolazamide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00116	CcSEcCtD
Tolazamide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Tolazamide—Chlorpropamide—ABCB1—peripheral nervous system neoplasm	0.000673	0.597	CrCbGaD
Tolazamide—Glyburide—ABCB1—peripheral nervous system neoplasm	0.000455	0.403	CrCbGaD
